Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Megna

Showing results (171-180 of 251) with videos related to

Pageof 26
Sort By:
Dermatology Reports|August 18, 2025
Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case seriesAndrea D'Arino, Maria Concetta Fargnoli, Pasquale Frascione, et al.
Rheumatology (Oxford, England)|July 3, 2025
TNF-alpha inhibitors reduce the incidence of psoriatic arthritis in patients with psoriasis: a propensity score-matched cohort studyStefano Piaserico, Matteo Megna, Federico Bardazzi, et al.
Clinical and Experimental Dermatology|December 4, 2021
Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?Matteo Megna, Giuseppina Caiazzo, Melania Parisi, et al.
Journal of Clinical Medicine|March 25, 2022
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and ApplicationsClaudio Marasca, Maria Carmela Annunziata, Elisa Camela, et al.
International Journal of Dermatology|May 22, 2026
The Psoriasis-Eczema Interface: Clinical Classification and Therapeutic Implications From a Bicentric ExperienceMichela D'Agostino, Gennaro Marco Falco, Eleonora De Luca, et al.
Clinical and Experimental Rheumatology|January 9, 2026
Intercepting the psoriasis-psoriatic arthritis continuum: a precision-medicine framework for at-risk, subclinical, and early psoriatic arthritisFrancesco Caso, Mario Cascone, Nicolò Girolimetto, et al.
Expert Opinion on Drug Safety|January 31, 2023
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patientsMatteo Megna, Elisa Camela, Teresa Battista, et al.
Critical Reviews in Food Science and Nutrition|February 13, 2023
The effect of the ketogenic diet on Acne: Could it be a therapeutic tool?Luigi Barrea, Sara Cacciapuoti, Matteo Megna, et al.
Dermatologic Therapy|February 14, 2022
Risankizumab shows high efficacy and maintenance in improvement of response until week 52Luca Mastorino, Sara Susca, Matteo Megna, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|December 4, 2015
Psoriasis in melanoma patients: a prospective pilot studyMatteo Megna, Maddalena Napolitano, Nicola Balato, et al.
Pageof 26

Showing results (171-180 of 251) with videos related to

Sort By:
Pageof 26
Dermatology Reports|August 18, 2025
Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case seriesAndrea D'Arino, Maria Concetta Fargnoli, Pasquale Frascione, et al.
Rheumatology (Oxford, England)|July 3, 2025
TNF-alpha inhibitors reduce the incidence of psoriatic arthritis in patients with psoriasis: a propensity score-matched cohort studyStefano Piaserico, Matteo Megna, Federico Bardazzi, et al.
Clinical and Experimental Dermatology|December 4, 2021
Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?Matteo Megna, Giuseppina Caiazzo, Melania Parisi, et al.
Journal of Clinical Medicine|March 25, 2022
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and ApplicationsClaudio Marasca, Maria Carmela Annunziata, Elisa Camela, et al.
International Journal of Dermatology|May 22, 2026
The Psoriasis-Eczema Interface: Clinical Classification and Therapeutic Implications From a Bicentric ExperienceMichela D'Agostino, Gennaro Marco Falco, Eleonora De Luca, et al.
Clinical and Experimental Rheumatology|January 9, 2026
Intercepting the psoriasis-psoriatic arthritis continuum: a precision-medicine framework for at-risk, subclinical, and early psoriatic arthritisFrancesco Caso, Mario Cascone, Nicolò Girolimetto, et al.
Expert Opinion on Drug Safety|January 31, 2023
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patientsMatteo Megna, Elisa Camela, Teresa Battista, et al.
Critical Reviews in Food Science and Nutrition|February 13, 2023
The effect of the ketogenic diet on Acne: Could it be a therapeutic tool?Luigi Barrea, Sara Cacciapuoti, Matteo Megna, et al.
Dermatologic Therapy|February 14, 2022
Risankizumab shows high efficacy and maintenance in improvement of response until week 52Luca Mastorino, Sara Susca, Matteo Megna, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|December 4, 2015
Psoriasis in melanoma patients: a prospective pilot studyMatteo Megna, Maddalena Napolitano, Nicola Balato, et al.
Pageof 26